One of the commonest tests for detecting the presence of prostate cancer is the prostate specific antigen, or PSA, test. In some cases PSA testing is now included as part of routine medical examinations for men over the age of 40 and, for men with a family history of prostate cancer, may be carried out at even earlier ages. It is also becoming increasingly common for doctors to perform a digital rectal examination at the same time as the PSA test for men over the age of 50 as an additional physical check of the prostate gland.
In conducting the PSA test your doctor will take a sample of blood which is then sent to a laboratory for testing. The laboratory will then measure the level of the prostate specific antigen protein and report its findings back to your doctor.
- APOPTOSIS: programmed cell death due to an alteration in a critical substance or chemical necessary for cell viability; the lack of male hormones causes apoptosis of androgen-dependent prostate cancer.
- DOSIMETRY: relating to the doses of radiation employed in treating a tumor.
- LOCALIZED: restricted to a well defined area.
- UTI (URINARY TRACT INFECTION): an infection identifiable by the presence of bacteria (or theoretically viruses) in the urine; may be associated with fever or a burning sensation on urination.
If the results show an abnormally high level of PSA then, unless the level is especially high, your doctor may advise that this indicates a possible prostate problem which could be anything from a temporary prostate infection to an enlarged prostate or possibly prostate cancer.
Many prostate problems are slow to develop and so repeat testing is frequently carried out over a long period of time with your doctor merely monitoring the results and charting what is sometimes referred to as the 'velocity' of your PSA. In other words, as long as your PSA levels are increasing, your doctor will monitor the speed of this increase until he feels that further testing is necessary.
There is some controversy surrounding the PSA test, not least because it does not provide a clear cut ‘yes’ or ‘no’ diagnosis for prostate cancer. Nevertheless it is an extremely valuable test for detecting early signs of problems developing within the prostate gland and is responsible for preventing many prostate cancer deaths each year.